Surgery for T4 breast carcinoma: implications for local control.

Area of Science:

• Oncology
• Surgical Oncology
• Breast Cancer Research

Background:

• Locally advanced breast cancer (LABC) presents a significant clinical challenge despite mammography availability.
• T4 carcinoma, including inflammatory breast cancer, represents a subset of LABC requiring specialized management.
• The role of surgery in LABC remains a subject of ongoing investigation and debate.

Purpose of the Study:

• To evaluate the outcomes of multimodality management for patients with T4 breast cancer.
• To assess the clinical response to neoadjuvant therapy in LABC.
• To analyze surgical outcomes, including complications and local control, in the management of LABC.

Main Methods:

• Retrospective review of 47 patients with clinical T4 breast cancer treated between 1993 and 1998.
• Analysis of neoadjuvant chemotherapy response, surgical procedures (mastectomy, breast conservation), and adjuvant treatments.
• Evaluation of perioperative complications, wound healing, and rates of local recurrence.

Main Results:

• 72% of patients received neoadjuvant chemotherapy, with 73.5% achieving partial or complete clinical response.
• 46 patients underwent mastectomy; one had breast conservation. Twelve required tissue transfer for wound coverage.
• Pathologically negative margins were achieved in all but one patient, with an 87% rate of no local recurrence at the time of follow-up.

Conclusions:

• Locally advanced breast cancer is a recurring issue in specific patient demographics.
• Multimodality treatment, integrating neoadjuvant therapy and surgical resection, is the established standard of care for LABC.
• Surgical intervention plays a crucial role in achieving successful local control and potential long-term cure for patients with T4 breast cancer.